Navigation Links
Recruiting engineered cells to work for warfighters
Date:4/8/2013

ARLINGTON, Va.The Office of Naval Research (ONR) today launched a collaborative initiative with university researchers focused on synthetic, or engineered, cellspart of a larger effort to use the smallest units of life to help Sailors and Marines execute their missions.

ONR currently has multiple ongoing projects in the field of synthetic biology, which offers new tools and methods for creating new organisms with specific functions, such as threat monitoring.

Even the simplest cells can have complex functions, such as being able to move in a particular direction or glow in the dark. The idea is to make these capabilities useful to humans by directing their natural functions and adding non-natural functions to a cell's repertoire.

In one instance, ONR is examining synthetic cell circuitsgenetic programs designed by scientists either to make a cell perform a certain task or change the way a cell would normally do the task. For example, plants have been engineered to turn white when they detect trinitrotoluene (TNT) as a visual cue to their handlers.

"We're developing better ways to program cells to detect things we're interested inlike explosivesand then communicate that they've found that chemical to a device like a robot," said Dr. Linda Chrisey, ONR program officer for naval biosciences and bio-centric technology. "For example, you could grow these special cells on a silicon chip that's part of a robot. When the cells detect something and respond, they would communicate this information to the 'mother ship'the autonomous robot system."

One of ONR's biggest successes to date was a TNT-detecting plant. This "plant sentinel" transitioned to the Defense Threat Reduction Agency and Department of Homeland Security in 2010. A small company was founded to modify this plant for other applications, such as chemical warfare detection and crop security.

"The grand plan is to try and take advantage of the natural capabi
'/>"/>

Contact: Peter Vietti
onrcsc@onr.navy.mil
703-588-2167
Office of Naval Research
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Market Analysis: Biomaterials and Engineered Protein
2. Painting with catalysts: Nano-engineered materials for detoxifying water by use of sunlight
3. Engineered bacteria make fuel from sunlight
4. Production of 5-aminovaleric and glutaric acid by metabolically engineered microorganism
5. Engineered immune cells produce complete response in child with an aggressive pediatric leukemia
6. Leukemia patients remain in remission more than 2 years after engineered T cell therapy
7. Bioengineered marine algae expands environments where biofuels can be produced
8. Soft Robotics: A groundbreaking new journal on engineered soft devices that Interact with Living Systems
9. Engineered bacteria can make the ultimate sacrifice
10. Ecologist: Genetically engineered algae for biofuel pose potential risks that should be studied
11. Success of engineered tissue depends on where its grown
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2015)... N.J. , June 25, 2015  TAKE Solutions ... a patent by the United States Patent and Trademark ... Standardization". This process leverages TAKE Solutions, Clinical Accelerators to ... over 50% (when compared to standardization without the accelerators), ... At the heart of ...
(Date:6/24/2015)... 24, 2015 Biometry authentication provider KeyLemon ... password solution one face in. ... one face in, entering the expanding biometric authentication ... multifactor-authentication biometric answer to the password problem. With ... partnership with KeyLemon, one face in allows users ...
(Date:6/18/2015)... This report analyzes the worldwide markets for ... Segments, which includes Immunoassay Analyzers and Reagents: Enzyme Immunoassay ... Systems, and Nephelometric Immunoassay Systems. The report provides separate ... , Japan , Europe ... Latin America , and Rest of World. Annual ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29
... first time, researchers have,automatically grouped fluorescently tagged ... feat opens a new way to,identify disease ... show which,proteins cluster together inside a cell.,The ... visual methods to localize proteins inside cells, ...
... that the bacterium that causes dysentery uses a 'sword ... research published today in Science, the team from Imperial ... the bacteria which causes dysentery, is able to invade ... , They found that shigella was able to infect ...
... insight into,the cause of certain kinds of UV-induced ... The Netherlands) have,employed an evolutionarily ancient enzyme-repair system ... for the onset of skin-tumor,development. The researchers' findings ... in developing preventative therapies against skin,cancer. , Ultraviolet ...
Cached Biology News:New, automated tool successfully classifies and relates proteins in unprecedented way 2Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer 2
(Date:7/3/2015)... Forskare kan ansöka ... http://www.openinnovationinscience.at till det återkommande utbildningsprogrammet "Lab ... i Wien .  ... forskare och vetenskapsmän som genomfördes av Ludwig ... utmaningar bristen på incitament för att undersöka ...
(Date:7/2/2015)... GLEN ELLYN, Ill. , July 2, 2015 /PRNewswire-USNewswire/ ... and Colton Eakins are gaining invaluable real-world ... Institute of Technology this summer. The students ... Dr. Jeff Wereszczynski,s research group at IIT. ... Professors Dr. Tom Carter , Physics; Dr. ...
(Date:7/1/2015)... ... 2015 , ... It is now possible to separate two common disorders: post-traumatic ... tomography (SPECT) according to researchers from Amen Clinics, UCLA, Thomas Jefferson University, and ... is believed to be the largest brain imaging study ever, will be published on ...
(Date:7/1/2015)... 2015   Neuraltus Pharmaceuticals, Inc. , a privately-held ... drugs to treat neurodegenerative diseases such as amyotrophic ... G. Miller , M.D., Director of the Forbes Norris ... Medical Center in San Francisco, has been awarded a ... to help fund a Phase 2 clinical study ...
Breaking Biology Technology:Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3COD Students Participate in Prestigious Summer Internships 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4
... SEATTLE, March 6 Dendreon Corporation,(Nasdaq: DNDN ) will release ... will host a conference call at,8:00 a.m. PT; 11:00 a.m. ET ... Access to the discussion may be,obtained as follows:, ... Date: March 13, 2008 ...
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,(TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or ... year ended December 31, 2007., "2007 was ... significant,expansion of the Company,s clinical trial program for ... studies being expanded and,initiated," said Dr. Brad Thompson, ...
... announces that it has,purchased 75% of Hisyn ... already issued the necessary business license and ... The acquisition provides Hovione with significant additional ... 20 year,presence in China. The acquisition includes ...
Cached Biology Technology:-Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET- 2Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 2Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 3Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 4Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 5Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 6Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 7Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 8Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007 9Hovione Buys Drug Manufacturing Facility in China 2
Contains 100 positive controls for effective screening of HDAC inhibitors by fluorometric method....
... structurally and functionally related BMPs, which are ... originally identified as protein regulators of cartilage ... in embryogenesis and morphogenesis of various tissues ... chemotaxis and apoptosis of various cell types, ...
dynactin 4, mRNA (cDNA clone MGC:3248 IMAGE:3505855), complete cds...
RABBIT ANTI HUMAN TRRAP (CT) Immunogen: Recombinant C-terminal kinase-related domain of human TRRAP....
Biology Products: